Rewriting the Rules for CBD medicine

New federal rules are changing the landscape for cannabinoid health products by tightening limits on THC in CBD. What happens when CBD is treated as true medicine? Dr. Priyanka Sharma, a chemical engineer and Co-CEO of Kazmira Therapeutics is leading innovation in high-purity, non-intoxicating cannabinoids. She breaks down what these changes mean for safety, patient care and the future of personalized CBD therapeutics.